Supernus Pharmaceuticals Inc (SUPN)

Inventory turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Cost of revenue (ttm)	US$ in thousands	321,031	418,757	454,848	468,008	467,442	489,145	440,870	414,500	382,420	340,324	326,355	288,181	258,697	221,602	190,722	179,160	176,685	183,085	182,916	181,669
Inventory	US$ in thousands	77,408	83,480	90,560	91,147	91,541	83,165	84,860	88,795	85,959	60,155	58,391	50,226	48,325	42,465	35,338	24,418	26,628	25,504	26,024	26,518
Inventory turnover		4.15	5.02	5.02	5.13	5.11	5.88	5.20	4.67	4.45	5.66	5.59	5.74	5.35	5.22	5.40	7.34	6.64	7.18	7.03	6.85

December 31, 2023 calculation

Inventory turnover = Cost of revenue (ttm) ÷ Inventory
= $321,031K ÷ $77,408K
= 4.15

Supernus Pharmaceuticals Inc's inventory turnover has shown a slight increasing trend over the past eight quarters, reaching 1.08 in Q4 2023 compared to the lowest point of 0.87 in Q2 2022. This indicates that the company is managing its inventory more efficiently and effectively in recent quarters. Generally, a higher inventory turnover implies that the company is selling its products more quickly, which is a positive sign as it reduces the risk of obsolete inventory and holding costs. However, it is important to consider industry benchmarks and compare with competitors to gain a deeper insight into the company's inventory management performance.